Announcement on Cancellation of Some Accounts for Raised Funds
Filed with SSE · · 2 pages · Chinese
Earlier from Sinotherapeutics
- Announcement on Attending Semi-annual Collective Performance Briefing for Enterprises in Biological Products and CXO Industries on SSE STAR Market 2025
- Special Report on Semi-annual Deposit and Use of Raised Funds in 2025
- Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
- Announcement on Using Partial Idle Raised Funds for Cash Management
- Announcement on Voluntary Disclosure of Obtaining EU GMP Certification by the Wholly-owned Subsidiary
Later from Sinotherapeutics
- Announcement on Voluntary Disclosure of Obtaining Marketing Approval by the National Medical Products Administration for the New Strength of Sitagliptin and Metformin Hydrochloride Sustained-release Tablets
- Announcement on Increasing Estimated Amount of Daily Related Party Transactions in 2025
- Announcement on Pledge of Partial Shares by Shareholders with Over 5% of Shares
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
- Announcement on Release of Pledge of Partial Shares Held by Shareholders with Over 5% Shares
Follow Sinotherapeutics into a list and get an email when it puts out news.
Follow Sinotherapeutics